Expert panel consensus statement on the optimal use of pomalidomide in relapsed and refractory multiple myeloma

M.A. Dimopoulos; X. Leleu; A. Palumbo; P. Moreau; M. Delforge; M. Cavo; H. Ludwig; G.J. Morgan; F.E. Davies; P. Sonneveld; S.A. Schey; S. Zweegman; M. Hansson; K. Weisel; M.V. Mateos; T. Facon; J.F.S. Miguel

doi:https://doi.org/10.1038/leu.2014.60

Expert panel consensus statement on the optimal use of pomalidomide in relapsed and refractory multiple myeloma

M.A. Dimopoulos, X. Leleu, A. Palumbo, P. Moreau, M. Delforge, M. Cavo, H. Ludwig, G.J. Morgan, F.E. Davies, P. Sonneveld, S.A. Schey, S. Zweegman, M. Hansson, K. Weisel, M.V. Mateos, T. Facon, J.F.S. Miguel

Hematology (VUmc)

Research output: Contribution to journal › Article › Academic › peer-review

99 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	1573-1585
Journal	Leukemia
Volume	28
Issue number	8
DOIs	https://doi.org/10.1038/leu.2014.60
Publication status	Published - 2014

Access to Document

https://doi.org/10.1038/leu.2014.60

Cite this

Dimopoulos, M. A., Leleu, X., Palumbo, A., Moreau, P., Delforge, M., Cavo, M., Ludwig, H., Morgan, G. J., Davies, F. E., Sonneveld, P., Schey, S. A., Zweegman, S., Hansson, M., Weisel, K., Mateos, M. V., Facon, T., & Miguel, J. F. S. (2014). Expert panel consensus statement on the optimal use of pomalidomide in relapsed and refractory multiple myeloma. Leukemia, 28(8), 1573-1585. https://doi.org/10.1038/leu.2014.60

@article{e4763b23c0274e9489cfe7bd52c80abd,

title = "Expert panel consensus statement on the optimal use of pomalidomide in relapsed and refractory multiple myeloma",

author = "M.A. Dimopoulos and X. Leleu and A. Palumbo and P. Moreau and M. Delforge and M. Cavo and H. Ludwig and G.J. Morgan and F.E. Davies and P. Sonneveld and S.A. Schey and S. Zweegman and M. Hansson and K. Weisel and M.V. Mateos and T. Facon and J.F.S. Miguel",

year = "2014",

doi = "https://doi.org/10.1038/leu.2014.60",

language = "Undefined/Unknown",

volume = "28",

pages = "1573--1585",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Nature Publishing Group",

number = "8",

}

Dimopoulos, MA, Leleu, X, Palumbo, A, Moreau, P, Delforge, M, Cavo, M, Ludwig, H, Morgan, GJ, Davies, FE, Sonneveld, P, Schey, SA, Zweegman, S, Hansson, M, Weisel, K, Mateos, MV, Facon, T & Miguel, JFS 2014, 'Expert panel consensus statement on the optimal use of pomalidomide in relapsed and refractory multiple myeloma', Leukemia, vol. 28, no. 8, pp. 1573-1585. https://doi.org/10.1038/leu.2014.60

TY - JOUR

T1 - Expert panel consensus statement on the optimal use of pomalidomide in relapsed and refractory multiple myeloma

AU - Dimopoulos, M.A.

AU - Leleu, X.

AU - Palumbo, A.

AU - Moreau, P.

AU - Delforge, M.

AU - Cavo, M.

AU - Ludwig, H.

AU - Morgan, G.J.

AU - Davies, F.E.

AU - Sonneveld, P.

AU - Schey, S.A.

AU - Zweegman, S.

AU - Hansson, M.

AU - Weisel, K.

AU - Mateos, M.V.

AU - Facon, T.

AU - Miguel, J.F.S.

PY - 2014

Y1 - 2014

U2 - https://doi.org/10.1038/leu.2014.60

DO - https://doi.org/10.1038/leu.2014.60

M3 - Article

C2 - 24496300

SN - 0887-6924

VL - 28

SP - 1573

EP - 1585

JO - Leukemia

JF - Leukemia

IS - 8

ER -